Search Results 671-680 of 15981 for larazotide acetate

  1. Glasdegib (oral route) - Mayo Clinic

    Glasdegib is used together with low-dose cytarabine to treat newly-diagnosed acute myeloid leukemia (AML) in adults 75 years of age and older or who have other ...

  2. Overview - Translational Cell Biology of Parkinson's Disease Laboratory - Mayo Clinic Research

    Dr. Springer's Translational Cell Biology of Parkinson's Disease Lab at Mayo Clinic studies the molecular roles underlying neurodegenerative disorders.

  3. Phase 1b Acute Myelogenous Leukemia (AML) Study With ABT-199 + Decitabine or Azacitidine (Chemo Combo) - Mayo Clinic

    This is a Phase 1b, open-label, non-randomized, multicenter study to evaluate the safety of orally administered ABT-199 combined with decitabine or azacitidine ...

  4. Plerixafor (subcutaneous route) - Mayo Clinic

    Plerixafor injection is used in combination with filgrastim to mobilize hematopoietic stem cells (HSC) for collection and transplantation in patients with non- ...

  5. Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). - Mayo Clinic

    Single Arm: The purpose of this trial is to evaluate the safety and effectiveness of transcatheter aortic valve implementation (TAVI) in patients with sever ...

  6. Laboratory Medicine and Pathology - Clinical Trials

    This project will investigate whether the analysis of nucleic acids circulating in the blood from tumors can allow real-time monitoring of treatment ...

  7. Imatinib (oral route) - Mayo Clinic

    Myelodysplastic syndrome (MDS); Myeloproliferative diseases (MPD); Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL); Philadelphia ...

  8. A Study of Vutrisiran (ALN-TTRSC02) in Patients with Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vutrisiran (ALN-TTRSC02) in patients with hereditary transthyretin amyloidosis (hATTR ...

  9. A Study to Learn More About Characterization of Different Musculoskeletal Tissues - Mayo Clinic

    About this study. The purpose of this investigation is to characterize the genetic and epigenetic characteristics of different musculoskeletal tissues, ...

  10. Overview - Anticancer Drug Action Laboratory - Mayo Clinic Research

    The Anticancer Drug Action Lab of Scott Kaufmann, M.D., Ph.D., at Mayo Clinic studies the mechanism of action of anti-cancer drugs, tumor cell sensitivity, ...